Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty
…, CL Cohen-Bernstein, R Grosswald, HA Liberman… - Circulation, 1995 - Am Heart Assoc
Background Although patients with diabetes mellitus constitute an important segment of the
population undergoing coronary angioplasty, the outcome of these patients has not been …
population undergoing coronary angioplasty, the outcome of these patients has not been …
Coronary stent restenosis in patients treated with cilostazol
…, E Block, ZMB Ghazzal, DC Morris, H Liberman… - Circulation, 2005 - Am Heart Assoc
Background— Restenosis after implantation of coronary artery stents remains a significant
clinical problem. We undertook a randomized, double-blind, placebo-controlled trial to …
clinical problem. We undertook a randomized, double-blind, placebo-controlled trial to …
Identification of patients and plaques vulnerable to future coronary events with near-infrared spectroscopy intravascular ultrasound imaging: a prospective, cohort …
…, D Lee, T Lalonde, W Skinner, A Villa, H Liberman… - The Lancet, 2019 - thelancet.com
Background Near-infrared spectroscopy (NIRS) intravascular ultrasound imaging can detect
lipid-rich plaques (LRPs). LRPs are associated with acute coronary syndromes or …
lipid-rich plaques (LRPs). LRPs are associated with acute coronary syndromes or …
Hybrid coronary revascularization for the treatment of multivessel coronary artery disease: a multicenter observational study
…, M Argenziano, T Vassiliades, H Liberman… - Journal of the American …, 2016 - jacc.org
Background : Hybrid coronary revascularization (HCR) combines minimally invasive surgical
coronary artery bypass grafting of the left anterior descending artery with percutaneous …
coronary artery bypass grafting of the left anterior descending artery with percutaneous …
Hybrid coronary revascularization versus off-pump coronary artery bypass grafting for the treatment of multivessel coronary artery disease
…, JS Douglas, DC Morris, ST Rab, HA Liberman… - The Annals of Thoracic …, 2011 - Elsevier
BACKGROUND: Hybrid coronary revascularization (HCR) combines a minimally invasive (3-cm
anterolateral thoracotomy), sternal-sparing, off-pump left internal mammary artery–left …
anterolateral thoracotomy), sternal-sparing, off-pump left internal mammary artery–left …
Safety of catheter‐directed thrombolysis for massive and submassive pulmonary embolism: results of a multicenter registry and meta‐analysis
…, BC Sandvall, HA Liberman… - Catheterization and …, 2017 - Wiley Online Library
Objectives To evaluate the safety and efficacy of catheter‐directed thrombolysis (CDT) in the
treatment of acute pulmonary embolism (PE). Background The use of CDT for the treatment …
treatment of acute pulmonary embolism (PE). Background The use of CDT for the treatment …
[HTML][HTML] Early clinical and angiographic outcomes after robotic-assisted coronary artery bypass surgery
ME Halkos, HA Liberman, C Devireddy… - The Journal of thoracic …, 2014 - Elsevier
Objective Robotic-assisted coronary artery bypass grafting has emerged as an alternative to
traditional coronary artery bypass grafting or percutaneous intervention for patients with …
traditional coronary artery bypass grafting or percutaneous intervention for patients with …
Angioplasty or surgery for multivessel coronary artery disease: comparison of eligible registry and randomized patients in the EAST trial and influence of treatment …
…, RA Guyton, DC Morris, HA Liberman… - The American journal of …, 1997 - Elsevier
The Emory Angioplasty versus Surgery Trial (EAST) showed that multivessel patients eligible
for both percutaneous transluminal coronary angioplasty (PTCA) and coronary bypass …
for both percutaneous transluminal coronary angioplasty (PTCA) and coronary bypass …
A multicenter, randomized, placebo-controlled trial of a new form of intravenous recombinant tissue-type plasminogen activator (activase) in acute myocardial …
…, CR Taylor, A Nishikawa, HA Liberman… - Journal of the American …, 1987 - Elsevier
A new, predominantly single chain preparation of recombinant tissue-type plasminogen
activator was evaluated to determine coronary thrombolytic efficacy in 100 patients with acute …
activator was evaluated to determine coronary thrombolytic efficacy in 100 patients with acute …
Improved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the …
…, E Nikolsky, DE Cutlip, L Mauri, H Liberman… - JACC: Cardiovascular …, 2010 - jacc.org
Objectives : The increased frequency of very late (>1 year) stent thrombosis (VLST) has raised
concerns with regard to the safety of sirolimus-eluting stents and paclitaxel-eluting stents (…
concerns with regard to the safety of sirolimus-eluting stents and paclitaxel-eluting stents (…